Universal screening for Hepatitis C in pregnant women
Official title: Universal HCV screening in pregnancy: Examining testing uptake and HCV care
Funded at Weill Medical Coll of Cornell Univ · NIH-11047092 · Data updated 2026-11-12
This study is looking at how well universal Hepatitis C testing during pregnancy is working, especially for women who use drugs, to see if more pregnant women are getting tested and if it helps both them and their babies get the care they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 30, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $707,647 |
| NIH project number | 1R01DA060499-01A1 |
| Project ID | NIH-11047092 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include pregnant women, particularly those who inject drugs or are at risk for HCV infection.
✕Less likely to help
Patients who are not pregnant or who do not have risk factors for HCV infection may not benefit from this research.
What this research studies
This research investigates the effectiveness of universal Hepatitis C virus (HCV) screening during pregnancy, particularly focusing on women who inject drugs. It aims to assess whether recent guidelines recommending universal testing have led to increased testing rates among pregnant women and improved care for both mothers and their infants. By analyzing national Medicaid and commercial claims data, the study will evaluate the impact of these guidelines on HCV testing, treatment, and the identification of infants at risk for perinatal transmission. The goal is to ensure that more women receive the necessary care and that infants born to HCV-infected mothers are appropriately tested and treated.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for pregnant women and their infants by ensuring timely HCV testing and treatment.
How similar studies have gone: Previous research has shown that universal screening approaches can significantly improve health outcomes in similar populations, indicating potential success for this initiative.
Where this research is happening
-
Weill Medical Coll of Cornell Univ
New York, United States Active
Researchers
- Principal investigator: Kapadia, Shashi — Weill Medical Coll of Cornell Univ
- Study coordinator: Kapadia, Shashi
Related research
Other NIH-funded projects on the same topics.
-
How air pollution during pregnancy affects fetal growth over time
This study looks at how air pollution affects the growth of babies in the womb during pregnancy, using ultrasound images to track changes over time, and it aims to help expectant parents understand when their babies might be most at risk from pollution.
-
Postoperative Pain Guidelines for Pregnancy: Safer, Patient-Centered Opioid Use
We’re creating patient-friendly guidelines to help doctors manage pain after delivery and surgery in pregnant people, aiming to reduce opioid overuse and improve safety.
-
HPV and pregnancy risk: a big study following 1,280 pregnancies
A large pregnancy study at UTMB looks at whether human papillomavirus (HPV) during pregnancy is linked to problems like preterm birth.
-
Understanding how where you live and personal factors during pregnancy affect a child’s risk for obesity and metabolic problems
This project looks at how neighborhood conditions and individual factors during pregnancy may influence a child’s risk of obesity and metabolic health as they grow.
-
Blocking cancer-causing cMYC tricks after pregnancy changes in the breast
Researchers are testing how pregnancy and aging reshape the breast before cancer risk, using patient-reinformed models to see if it changes how dangerous cMYC signals behave.
-
SSRI use during pregnancy: effects on placental blood flow and inflammation
This grant studies how antidepressants (SSRIs) used during pregnancy might affect the placenta and inflammation, and whether a 5-HT2 receptor blocker could mitigate any negative effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.